Patents by Inventor Clement Opoku-Temeng

Clement Opoku-Temeng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11891391
    Abstract: The present invention generally relates to compounds as a dual kinase-demethylase inhibitor useful for the treatment of diseases mediated by a kinase and/or a histone demethylase, such as inflammation, cancer, viral and bacterial infections, neurological and immunological disorders. Pharmaceutical compositions and methods for treating those diseases are within the scope of this invention.
    Type: Grant
    Filed: April 29, 2021
    Date of Patent: February 6, 2024
    Assignee: Purdue Research Foundation
    Inventors: Herman O. Sintim, Neetu Dayal, Clement Opoku-Temeng
  • Publication number: 20230391767
    Abstract: The present invention generally relates to compounds as a new antibiotic to treat various infections, including infections caused by methicillin-resistant Staphylococcus aureus, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecalis and Clostridioides difficile. Pharmaceutical compositions and methods for treating those diseases are within the scope of this invention.
    Type: Application
    Filed: August 21, 2023
    Publication date: December 7, 2023
    Inventors: Herman O. SINTIM, Mohamed SELEEM, Clement OPOKU-TEMENG, Haroon Taj MOHAMMAD, George NACLERIO
  • Patent number: 11731964
    Abstract: The present invention generally relates to compounds as a new antibiotic to treat various infections, including infections caused by methicillin-resistant Staphylococcus aureus, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecalis and Clostridioides difficile. Pharmaceutical compositions and methods for treating those diseases are within the scope of this invention.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: August 22, 2023
    Assignee: Purdue Research Foundation
    Inventors: Herman O. Sintim, Mohamed Seleem, Clement Opoku-Temeng, Haroon Taj Mohammad, George Naclerio
  • Publication number: 20210371420
    Abstract: The present invention generally relates to compounds as a dual kinase-demethylase inhibitor useful for the treatment of diseases mediated by a kinase and/or a histone demethylase, such as inflammation, cancer, viral and bacterial infections, neurological and immunological disorders. Pharmaceutical compositions and methods for treating those diseases are within the scope of this invention.
    Type: Application
    Filed: April 29, 2021
    Publication date: December 2, 2021
    Inventors: Herman O. Sintim, Neetu Dayal, Clement Opoku-Temeng
  • Patent number: 11040973
    Abstract: The present invention generally relates to compounds as a dual kinase-demethylase inhibitor useful for the treatment of diseases mediated by a kinase and/or a histone demethylase, such as inflammation, cancer, viral and bacterial infections, neurological and immunological disorders. Pharmaceutical compositions and methods for treating those diseases are within the scope of this invention.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: June 22, 2021
    Inventors: Herman O. Sintim, Neetu Dayal, Clement Opoku-Temeng
  • Publication number: 20210047316
    Abstract: The present invention generally relates to compounds as a new antibiotic to treat various infections, including infections caused by methicillin-resistant Staphylococcus aureus, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecalis and Clostridioides difficile. Pharmaceutical compositions and methods for treating those diseases are within the scope of this invention.
    Type: Application
    Filed: March 29, 2019
    Publication date: February 18, 2021
    Inventors: Herman O. SINTIM, Mohamed SELEEM, Clement OPOKU-TEMENG, Haroon Taj MOHAMMAD, George NACLERIO
  • Publication number: 20200308173
    Abstract: The present invention generally relates to compounds as a dual kinase-demethylase inhibitor useful for the treatment of diseases mediated by a kinase and/or a histone demethylase, such as inflammation, cancer, viral and bacterial infections, neurological and immunological disorders. Pharmaceutical compositions and methods for treating those diseases are within the scope of this invention.
    Type: Application
    Filed: March 29, 2018
    Publication date: October 1, 2020
    Inventors: Herman O. Sintim, Neetu Dayal, Clement Opoku-Temeng